Transparency key for drug sponsorship

Most viewed articles this week

• EULAR recommendations on neuropsychiatric effects of SLE (30/08/2010)
• New criteria for RA a 'game changer' (16/08/2010)
• GP delays cause worse outcomes in RA (30/08/2010)
• OTC analgesics require more monitoring: study (06/09/2010)
• Muscle pathology contributes to polymyalgia rheumatica (06/09/2010)

Recent comments

• Name withheld said "Whilst welcoming and supporting Geoff Littlejohn's research I look forward to the full publication so..."
• John Quintner said "The elephant may still be in the room but unfortunately many rheumatologists have long..."
• Jeffery said "The hypothesis around the study by Ms Jenks is a sound one: The idea that..."
• Gary Champion said "As a Private solo Rheumatologist I welcome the AMA Statement. As I do not receive..."
• Gary Champion said "As a Private solo Rheumatologist I welcome the AMA Statement. As I do not receive..."

Related sites

• 6minutes
• Australian Doctor
• Cardiology Update
• Endocrinology Update
• Gastroenterology Update
• Neurology Update
• Oncology Update
• Pharmacy News
• Psychiatry Update